Folate metabolizing gene polymorphisms and genetic vulnerability to preterm birth in Korean women

Background The folate metabolism that converts homocysteine to methionine is closely related to the accumulation of homocysteine. Increased homocysteine levels lead to an impaired antithrombotic function of the vascular endothelium and uterine-placental circulation, resulting in abnormal pregnancy outcomes. Previous studies have reported that gene polymorphisms in folate metabolism are associated with the development of preterm birth (PTB) in various populations. Objective we performed a case–control study to evaluate the association between five polymorphisms in folate metabolic genes ( MTHFR, MTR, MTRR, TCN2 ) and PTB. Methods In this study, a total of 254 subjects were analyzed (111 patients with PTB and 143 women at ≥ 38 weeks of gestation). Genotype and allele frequency differences between patients and control groups and the Hardy–Weinberg equilibrium were assessed using a Chi-square test. For evaluation indicators, odds ratios (ORs) of 95% confidence intervals (CI) were estimated. In addition, we analyzed the combined genotype frequencies of SNPs of folate-metabolizing genes to measure gene–gene interactions for PTB. Results Our results showed that the MTR rs1805087 GG ( p = 0.031), and TCN2 rs1801198 CG genotype (OR 0.53, 95% CI 0.288–0.980, p = 0.042) were significantly associated with PTB. The MTHFR rs4846049 AA showed a marginal trend toward significance (OR 0.15, 95% CI 0.018–1.205, p = 0.041). In particular, the combined genotypes, including MTHFR rs1537514 CC— MTRR rs1801394 GG, MTHFR rs1537514 CC— TCN2 rs1801198 CG, and MTR rs1805087 AA— TCN2 rs1801198 CG, have significant interactions with PTB (OR 0.49, 95% CI 0.248–0.992, p